NCT04453748View on ClinicalTrials.gov

The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

November 30, 2021

Conditions
COVID-19Coronavirus InfectionSars-CoV2Complications
Interventions
OTHER

Complex diagnostic panel

Complex, multidisciplinary diagnostic panel, including blood, imaging and functional tests.

Trial Locations (1)

41-800

Silesian Centre for Heart Disease, Zabrze

Sponsors
All Listed Sponsors
collaborator

Medical Research Agency, Poland

OTHER_GOV

collaborator

Medical University of Silesia

OTHER

lead

Silesian Centre for Heart Diseases

OTHER

NCT04453748 - The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications | Biotech Hunter | Biotech Hunter